Literature DB >> 19835969

Natural killer cells: tolerance to self and innate immunity to viral infection and malignancy.

Wayne M Yokoyama1, Marcus Altfeld, Katharine C Hsu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19835969      PMCID： PMC3900292          DOI： 10.1016/j.bbmt.2009.10.009

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN： 1083-8791            Impact factor:   5.742


× No keyword cloud information.
  81 in total

1.  The reactivity of Bw4+ HLA-B and HLA-A alleles with KIR3DL1: implications for patient and donor suitability for haploidentical stem cell transplantations.

Authors:  Bree A Foley; Dianne De Santis; Els Van Beelen; Louise J Lathbury; Frank T Christiansen; Campbell S Witt
Journal:  Blood       Date:  2008-04-02       Impact factor: 22.113

2.  Donor killer immunoglobulin-like receptor (KIR) genotype-patient cognate KIR ligand combination and antithymocyte globulin preadministration are critical factors in outcome of HLA-C-KIR ligand-mismatched T cell-replete unrelated bone marrow transplantation.

Authors:  Toshio Yabe; Keitaro Matsuo; Kouyuki Hirayasu; Koichi Kashiwase; Sumiyo Kawamura-Ishii; Hidenori Tanaka; Atsuko Ogawa; Minoko Takanashi; Masahiro Satake; Kazunori Nakajima; Katsushi Tokunaga; Hidetoshi Inoko; Hiroo Saji; Seishi Ogawa; Takeo Juji; Takehiko Sasazuki; Yoshihisa Kodera; Yasuo Morishima
Journal:  Biol Blood Marrow Transplant       Date:  2008-01       Impact factor: 5.742

3.  Effects of the NK cell recovery on outcomes of unmanipulated haploidentical blood and marrow transplantation for patients with hematologic malignancies.

Authors:  Ying-Jun Chang; Xiang-Yu Zhao; Xiao-Jun Huang
Journal:  Biol Blood Marrow Transplant       Date:  2008-03       Impact factor: 5.742

4.  Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands.

Authors:  Junli Yu; Glenn Heller; Joseph Chewning; Sungjin Kim; Wayne M Yokoyama; Katharine C Hsu
Journal:  J Immunol       Date:  2007-11-01       Impact factor: 5.422

5.  Human leukocyte antigens A23, A24, and A32 but not A25 are ligands for KIR3DL1.

Authors:  Martin Stern; Loredana Ruggeri; Marusca Capanni; Antonella Mancusi; Andrea Velardi
Journal:  Blood       Date:  2008-05-23       Impact factor: 22.113

6.  Sustained NKG2D engagement induces cross-tolerance of multiple distinct NK cell activation pathways.

Authors:  Jérôme D Coudert; Léonardo Scarpellino; Frédéric Gros; Eric Vivier; Werner Held
Journal:  Blood       Date:  2008-01-15       Impact factor: 22.113

7.  Increased proportion of KIR3DS1 homozygotes in HIV-exposed uninfected individuals.

Authors:  Salix Boulet; Saeid Sharafi; Nancy Simic; Julie Bruneau; Jean-Pierre Routy; Christos M Tsoukas; Nicole F Bernard
Journal:  AIDS       Date:  2008-03-12       Impact factor: 4.177

8.  Conferral of enhanced natural killer cell function by KIR3DS1 in early human immunodeficiency virus type 1 infection.

Authors:  Brian R Long; Lishomwa C Ndhlovu; Jorge R Oksenberg; Lewis L Lanier; Frederick M Hecht; Douglas F Nixon; Jason D Barbour
Journal:  J Virol       Date:  2008-02-27       Impact factor: 5.103

9.  Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes.

Authors:  Galit Alter; Maureen P Martin; Nickolas Teigen; William H Carr; Todd J Suscovich; Arne Schneidewind; Hendrik Streeck; Michael Waring; Angela Meier; Christian Brander; Jeffrey D Lifson; Todd M Allen; Mary Carrington; Marcus Altfeld
Journal:  J Exp Med       Date:  2007-11-19       Impact factor: 14.307

10.  Inhibitory KIR-HLA receptor-ligand mismatch in autologous haematopoietic stem cell transplantation for solid tumour and lymphoma.

Authors:  W Leung; R Handgretinger; R Iyengar; V Turner; M S Holladay; G A Hale
Journal:  Br J Cancer       Date:  2007-07-31       Impact factor: 7.640
View more
  10 in total

1.  In utero transplantation: Disparate ramifications.

Authors:  John S Pixley; Esmail D Zanjani
Journal:  World J Stem Cells       Date:  2013-04-26       Impact factor: 5.326

Review 2.  How important is NK alloreactivity and KIR in allogeneic transplantation?

Authors:  Brian C Shaffer; Katharine C Hsu
Journal:  Best Pract Res Clin Haematol       Date:  2016-10-20       Impact factor: 3.020

3.  All is fair in virus-host interactions: NK cells and cytomegalovirus.

Authors:  Marina Babić; Astrid Krmpotić; Stipan Jonjić
Journal:  Trends Mol Med       Date:  2011-08-17       Impact factor: 11.951

Review 4.  Natural killer cell education and tolerance.

Authors:  Mark T Orr; Lewis L Lanier
Journal:  Cell       Date:  2010-09-17       Impact factor: 41.582

5.  Mouse natural killer (NK) cells express the nerve growth factor receptor TrkA, which is dynamically regulated.

Authors:  Natacha Ralainirina; Nicolaas H C Brons; Wim Ammerlaan; Céline Hoffmann; François Hentges; Jacques Zimmer
Journal:  PLoS One       Date:  2010-12-01       Impact factor: 3.240

6.  Immunoproteasome-deficiency has no effects on NK cell education, but confers lymphocytes into targets for NK cells in infected wild-type mice.

Authors:  Mary J G van Helden; Natascha de Graaf; Cornelis P J Bekker; Claire J P Boog; Dietmar M W Zaiss; Alice J A M Sijts
Journal:  PLoS One       Date:  2011-08-24       Impact factor: 3.240

Review 7.  History and current state of immunotherapy in glioma and brain metastasis.

Authors:  Tresa McGranahan; Gordon Li; Seema Nagpal
Journal:  Ther Adv Med Oncol       Date:  2017-02-01       Impact factor: 8.168

8.  Spatial Clustering of Receptors and Signaling Molecules Regulates NK Cell Response to Peptide Repertoire Changes.

Authors:  Berenice Mbiribindi; Sayak Mukherjee; Dannielle Wellington; Jayajit Das; Salim I Khakoo
Journal:  Front Immunol       Date:  2019-04-05       Impact factor: 7.561

9.  NK cells contribute to reovirus-induced IFN responses and loss of tolerance to dietary antigen.

Authors:  Pamela H Brigleb; Elaine Kouame; Kay L Fiske; Gwen M Taylor; Kelly Urbanek; Luzmariel Medina Sanchez; Reinhard Hinterleitner; Bana Jabri; Terence S Dermody
Journal:  JCI Insight       Date:  2022-08-22

10.  The Glycophosphatidylinositol Anchor of the MCMV Evasin, m157, Facilitates Optimal Cell Surface Expression and Ly49 Receptor Recognition.

Authors:  Lindsey E Carlin; Natalya V Guseva; Michael R Shey; Zuhair K Ballas; Jonathan W Heusel
Journal:  PLoS One       Date:  2013-06-19       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.